MedPath

Reversibility of adrenal function in Addison's disease.

Completed
Registration Number
NL-OMON28931
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Patients with Addison's disease;

2. Age: 18-75 years;

Exclusion Criteria

1. Acute stress or illness;

2. Use of other medication containing glucocorticoids;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cortisol concentration 30 and 60 minutes after Synacthen stimulation test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath